Pulmonx sees FY26 revenue $90M-$92M, consensus $94.23M

The company said, “Pulmonx (LUNG) expects revenue for the full year 2026 to be in the range of $90 million to $92 million. The Company expects gross margin for the full year 2026 to be approximately75%. Pulmonx expects total operating expenses for the full year 2026 to fall within the range of $113 million to $115 million, inclusive of approximately $21 million of non-cash stock-based compensation. The Company expects cash, cash equivalents, and marketable securities to decrease by approximately $23 million for the full year 2026 assuming no additional drawdowns under the Company’s recently closed credit facility.”